0
SPEAKER_00
Have you ever wanted to chat with Tony Robbins directly?
0
SPEAKER_00
Now you can, and it s as easy as texting him.
0
SPEAKER_00
That s right, Tony is part of Community, a new platform that allows you to communicate with him one-on-one.
0
SPEAKER_00
All you need to do is send him a text at 561-423-1444.
0
SPEAKER_00
That s 561-423-1444.
0
SPEAKER_00
Be sure to let him know what you think about this episode and all of the other life changing content he s making available to you at www.tonyromans.com slash resources.
0
SPEAKER_00
Welcome to the Tony Robbins Podcast.
0
SPEAKER_00
Today we have a very important episode for you.
0
SPEAKER_00
If you re like many people, you re probably trying to make sense of all of the information that s being shared 24 hours a day on television, headline news, and across social media channels around the world.
0
SPEAKER_00
It s a lot to keep up with, as new numbers and statistics about COVID-19 are being broadcast around the clock.
0
SPEAKER_00
In this episode, we re bringing you two longtime leading physicians to provide context and clarification of the facts that you re hearing.
0
SPEAKER_00
Dr. Peter Diamandis and Dr. Bob Hariri will break down the coronavirus data that you re seeing and hearing in the media.
0
SPEAKER_00
Dr. Hariri is a surgeon, a biomedical scientist, and a serial entrepreneur in biomedical technology.
0
SPEAKER_00
He s going to share some of his team s breakthroughs in a stem cell treatment that could be an effective solution for COVID-19.
0
SPEAKER_00
This episode was recorded on Thursday, April 9th.
0
SPEAKER_00
Here s Tony.
0
SPEAKER_01
Hey everybody, it s Tony Robbins.
0
SPEAKER_01
Listen, we have a really important program for you today.
0
SPEAKER_01
Shout out to all of you that I know are dealing with all kinds of stresses with the whole world being shut down.
0
SPEAKER_01
We have like 200, whatever the number of people, billion people that are shut down into their homes.
0
SPEAKER_01
And there s so much fear and there s so much uncertainty.
0
SPEAKER_01
And so the purpose of this particular program is to bring you some of the best experts in the world who can help you put this in context.
0
SPEAKER_01
Because a lot of what we ve heard and a lot of the decisions we ve made has been based on numbers that were projected to be accurate and haven t been accurate, unfortunately.
0
SPEAKER_01
No one s done anything wrong.
0
SPEAKER_01
Everybody s trying to protect our society, protect our world.
0
SPEAKER_01
And in so doing, there may be some overprotection.
0
SPEAKER_01
And so just like if you go hear a medical diagnosis today, most human beings know you should get a second opinion.
0
SPEAKER_01
Today, we re going to have some experts who are super qualified to be able to talk in this area because it s a pure expertise, try and give you a context of what we ve learned and where we really are, maybe dispel some of the fear.
0
SPEAKER_01
But then the majority of the time we really want to talk to is what are some of the solutions that are coming out that are true breakthroughs that can make a difference with this COVID-19 situation.
0
SPEAKER_01
And we re going to have a couple of guests, but who s going to be my partner today is my partner in real life, which is Peter Diamandis, who is my dear, dear friend.
0
SPEAKER_01
And we re partners together.
0
SPEAKER_01
He s the head of the XPRIZE.
0
SPEAKER_01
He created the XPRIZE.
0
SPEAKER_01
Most of you in my audience know who he is.
0
SPEAKER_01
executive founder of Singularity.
0
SPEAKER_01
He s, you know, multiple New York Times number one bestseller with Bold and Abundance and Bold Capital Partners.
0
SPEAKER_01
I mean, there s so many companies, I couldn t list them all.
0
SPEAKER_01
But Peter s joining us now.
0
SPEAKER_01
So, Peter, hello.
0
SPEAKER_01
Thanks for joining me, brother.
0
SPEAKER_01
Thanks for joining us.
0
SPEAKER_02
Thank you, brother.
0
SPEAKER_02
A pleasure.
0
SPEAKER_02
And, and yeah, it s a welcome.
0
SPEAKER_02
It s a pleasure.
0
SPEAKER_02
Welcome everybody as well.
0
SPEAKER_02
And, and during this time, we re all trying to understand what s going on with this pandemic, because it s both a viral pandemic and it s a pandemic of fear.
0
SPEAKER_02
And people are talking about what are the diagnostics available?
0
SPEAKER_02
What are the antivirals available?
0
SPEAKER_02
What are the vaccines available?
0
SPEAKER_02
More importantly, what are the therapeutics available?
0
SPEAKER_02
And we have an incredible guest that Tony will introduce in a second, who is another brother and a partner with us, one of the smartest people that we know.
0
SPEAKER_02
But I want to contextualize what we re going to speak about during the course of this hour plus.
0
SPEAKER_02
The first is, let s talk about what s truly going on around the world in terms of what are the real numbers?
0
SPEAKER_02
How fearful should you be?
0
SPEAKER_02
How hopeful or optimistic should you be that this might be over soon?
0
SPEAKER_02
or it s not as bad as people think it is.
0
SPEAKER_02
But the meat of this program is going to be a therapeutic treatment for COVID, for viral infections that you might not have heard about.
0
SPEAKER_02
And it s a concept of cellular medicine.
0
SPEAKER_02
So we re going to be talking about how do you augment your immunity with natural killer cells and with stem cells.
0
SPEAKER_02
An extraordinary scientist, physician, and CEO is with us.
0
SPEAKER_02
Tony, you want to go ahead and introduce?
0
SPEAKER_01
Yes, and I just want to say in this particular show, we may divide this in two to be honest, so we ll decide as it s here, but we re also going to bring you some people who are in the most advanced areas of testing.
0
SPEAKER_01
You ve all heard about antibody testing.
0
SPEAKER_01
Many people are saying this is the only way we really get back to work because the current tests that you re doing swabs on, we ll go into this a little bit later in the show here,
0
SPEAKER_01
First of all, not super accurate, a lot of false positives, but most importantly, it only tells you that you might have the virus now.
0
SPEAKER_01
It doesn t tell you if you developed antibodies.
0
SPEAKER_01
In fact, if your body is now, your immune system is strong and it ll fight off the virus, you don t have to worry about it.
0
SPEAKER_01
You re free to go back to your normal life.
0
SPEAKER_01
And so, it s pretty important, as well as a similar company that is working on a vaccine that s worked in this industry for more than 30 years, but a vaccine that may be accelerated in its tempo, not 18 months away, simply because the source of vaccine, as we ll walk through with them, doesn t actually use the virus itself.
0
SPEAKER_01
So, it s not so dangerous, but we ll get into that as well.
0
SPEAKER_01
So, it s a solution-oriented show, but we want to start by introducing Dr. Bob Howrey, MD, PhD,
0
SPEAKER_01
Bob is an incredible neurosurgeon.
0
SPEAKER_01
He s a biomedical student.
0
SPEAKER_01
He s a high-performance aviator.
0
SPEAKER_01
He s a serial entrepreneur in two technology sectors and biomedicine and aerospace both.
0
SPEAKER_01
He s truly a renaissance man.
0
SPEAKER_01
And he s our dear friend and partner.
0
SPEAKER_01
But I got a hold of Bob originally through Peter and I when I tore my rotator cuffs and kind of started on this journey of understanding cellular therapy because they were torn so badly during this snowboarding accident.
0
SPEAKER_01
that literally the doctor said, three different doctors, you have to have surgery, surgery immediately, the pain was incredible.
0
SPEAKER_01
And then the problem was the rehab, the three to six months of rehab where I wouldn t be able to clap, move and do things I do.
0
SPEAKER_01
And Bob was the one who taught me the difference in the different types of stem cells in the world and cellular therapy, and got me to the right type of treatment, the impact of which was one session, no exaggeration, and my rotator cuff is absolutely perfect.
0
SPEAKER_01
I can do everything I want to do.
0
SPEAKER_01
I have no downtime.
0
SPEAKER_01
I mean, it was life changing to me.
0
SPEAKER_01
So that entered me into this whole area of really looking at the change that s happening in medicine today and finding out as much as I could about cellular therapy.
0
SPEAKER_01
Bob is the chairman and founder and chief executive officer of Cellularity.
0
SPEAKER_01
It s one of the world s leading human cellular therapeutic companies.
0
SPEAKER_01
And he s a pioneer in stem cells and just a brilliant, brilliant guy.
0
SPEAKER_01
And he s also a straight shooter.
0
SPEAKER_01
So it s always fun to be with Bob.
0
SPEAKER_01
Bob, welcome to the program.
0
SPEAKER_01
Tony, great to see you.
0
SPEAKER_01
And Peter, thanks for having me on.
0
SPEAKER_01
Beautiful, buddy.
0
SPEAKER_01
Great to be with you, man.
0
SPEAKER_01
Listen, let s start with context.
0
SPEAKER_01
I mean, you re up there in New York.
0
SPEAKER_01
You see on the news every night there s a red frame or everything.
0
SPEAKER_01
More people dying, more people diagnosed.
0
SPEAKER_01
You and I both know diagnosed doesn t mean a whole lot.
0
SPEAKER_01
It s who gets hospitalized.
0
SPEAKER_01
They put these huge numbers up.
0
SPEAKER_01
And no one s trying to do anything wrong.
0
SPEAKER_01
They re trying to inform people.
0
SPEAKER_01
And unfortunately, using fear as the primary motivator,
0
SPEAKER_01
Can you give us a little context about what s really happening in the trenches, where we stand, and what the numbers were originally based on, that all these formulas that made us shut down the world economy are from Wuhan versus what we re finding now?
0
SPEAKER_03
So listen, we re living through an unprecedented event in global health.
0
SPEAKER_03
Viruses come and go all the time.
0
SPEAKER_03
Pandemics happen with a great deal of frequency.
0
SPEAKER_03
What s unique about this particular pandemic is the nature of the virus itself is somewhat different than what we are normally used to.
0
SPEAKER_03
And the somewhat nefarious origins of the virus have left people to be both
0
SPEAKER_03
on a hyper-vigilant, hyper-alert state, but also willing to react very aggressively to any negative news they hear.
0
SPEAKER_03
Now, the bottom line is the early
0
SPEAKER_03
evaluation and reports on the number of people who were infected and who had bad results from the infection was very alarming.
0
SPEAKER_03
If you go back six to eight weeks ago, the number of people that were shown to have the virus and were getting really sick
0
SPEAKER_03
was alarming because this was somewhat unusual for conventional flu, at least the way conventional flu is reported.
0
SPEAKER_03
Now, the fact is that we really don t fully understand when this virus first made landfall here in the United States.
0
SPEAKER_03
There are some who speculate that it may have come here as early as last fall.
0
SPEAKER_03
A virus like this has characteristics that dictate its rate of spray.
0
SPEAKER_03
Some of those characteristics are how long can somebody be carrying it and infected with it where they don t have symptoms, yet they can still infect others.
0
SPEAKER_03
If that period is long, then one person can interact with many, many more people and potentially be a source of infection for those people.
0
SPEAKER_03
Flu, influenza, the incubation period is relatively short, which means if you got it, within a few days, a day or two, you re starting to have symptoms.
0
SPEAKER_03
You isolate yourself naturally.
1
SPEAKER_01
from the crowd.
1
SPEAKER_01
You re not infecting that many people, but if you can carry it for 7 to 10 to 14 days, relatively asymptomatic, you may infect hundreds of people.
1
SPEAKER_01
And therefore, the exponent, how many people wind up ultimately getting exposed, is that much higher.
1
SPEAKER_01
It s very suspicious how quickly this particular viral infection affected many, many people.
1
SPEAKER_01
That s number one.
1
SPEAKER_01
Number two is that although the vast majority of people, probably 90% who are exposed and get infected actually have very mild or no symptoms at all.
1
SPEAKER_01
And these people don t even seek help of the physician or a hospital.
1
SPEAKER_01
but a small percentage that are going to the hospital and are seen to have in fact been infected do develop
1
SPEAKER_01
very severe complications.
1
SPEAKER_01
Those complications can include difficulty breathing, in some cases necessitating being on a ventilator, and we re actually learning more and more that the ventilatory problems are not like a conventional pneumonia.
1
SPEAKER_01
They may in fact be far more insidious.
1
SPEAKER_01
They may in fact involve the way oxygen gets across the lung into the blood and even how the oxygen is carried in the bloodstream.
1
SPEAKER_01
That being said,
1
SPEAKER_01
For roughly every 100 patients who is so alarmed that they go to the emergency room, 80 of them are sent home because they re not that sick.
1
SPEAKER_01
20 wind up staying in the hospital, and of that 20, four to six of those get sick enough they have to be put in the ICU.
1
SPEAKER_01
So the numbers are not that alarming, but remember, when the news first carried the possibilities that this pandemic could affect millions and millions of patients, and when the lethality rate was originally estimated to be as high as 5%, you know everyone panicked.
1
SPEAKER_01
People, if your wife or your child or your brother or your mother started to develop symptoms, you ran to the emergency room.
1
SPEAKER_01
Most people, with the amplitude of symptoms that they had,
1
SPEAKER_01
under normal circumstances, if this wasn t on the front page of every news, would stay home and rough it out.
1
SPEAKER_01
Exactly right.
1
SPEAKER_01
But in contrast, this was such a call, a crisis call.
1
SPEAKER_02
This fear produced mass number of people going to the hospital who wouldn t normally go there, overran the hospitals.
1
SPEAKER_02
That s right.
1
SPEAKER_02
Certainly gotten away in certain countries like Italy and so forth where they re able to operate normally and do what they normally do.
1
SPEAKER_02
But then also, all that fear was really based on algorithms that came from an initial small group of people from China who were extremely ill, not understanding who might be infected as a whole.
1
SPEAKER_02
So we re used to the flu with 20 to 40 million people being infected in the U.S.
1
SPEAKER_02
alone every year, and us having 35 to 80,000 deaths.
1
SPEAKER_02
Those seem normal.
1
SPEAKER_02
This year,
1
SPEAKER_02
The CDC says we have 39 million people infected with the flu.
1
SPEAKER_02
There have been 29,000 deaths here in the United States in this exact time period.
1
SPEAKER_02
And we ve had 200,000 hospital visits, but none of that gets reported because what s happening is what s new about this.
1
SPEAKER_02
We had zero cases and then we found the virus and now we started testing for whatever.
1
SPEAKER_02
And as you know, Bob, wherever we test, we find more and more of it.
1
SPEAKER_02
but it s changing the morbidity or the death rate.
1
SPEAKER_02
Everything was based on these algorithms.
1
SPEAKER_02
That s what Dr. Fauci and everyone else did with the best intent of protecting us and going three and a half, four and a half, five percent death rate versus flu, which might be zero point one, two or three or four, less than a half a percent.
1
SPEAKER_02
And they decided to take giant action.
1
SPEAKER_02
You know, Dr. Fauci is a good man.
1
SPEAKER_02
He s worked his tail off.
1
SPEAKER_02
He s been around, you know, 70 plus years old.
1
SPEAKER_02
He s been telling people up until now,
1
SPEAKER_02
Because it was his best estimate, all these formulas, we all know bad data in, bad data out, right?
1
SPEAKER_02
Algorithms don t, they re only as good as what you put in.
1
SPEAKER_02
These three and a half, four and a half percent morbidity rates they re talking about being far greater than the flu.
1
SPEAKER_02
He s now correcting that a week ago.
1
SPEAKER_02
This is New England Journal of Medicine, as you well know, one of the most respected journals in the United States.
1
SPEAKER_02
Let s read it together.
1
SPEAKER_02
March 26th.
1
SPEAKER_02
If one assumes that the number of asymptomatic, meaning no symptoms, or minimally symptomatic cases is several times as high as the number of recorded cases, the case fidelity rate may be considerably less than 1%.
1
SPEAKER_02
That suggests that the overall clinical consequence of COVID-19 may also be more akin to those of a severe seasonal influenza, which means flu, versus SARS or MERS, which were at nine, 10, and 36%.
1
SPEAKER_02
Yet, unfortunately, on the news, he committed years, you know, weeks ago, 200,000 to 2 million people were gonna die.
1
SPEAKER_02
And so he said it again, 200,000 probably, and they asked him in the news, you know, and reporters, you said 2 million.
1
SPEAKER_02
He goes, that s still possible.
1
SPEAKER_02
The numbers don t show enough to be true right now.
1
SPEAKER_02
And yet people are scared and we re shutting down our economy on it.
1
SPEAKER_02
So I d love your comments on these, because these are facts.
1
SPEAKER_02
They re not suggestions of some right-wing conspiracy.
1
SPEAKER_02
This is not saying there s conspiracy.
1
SPEAKER_02
It s just saying people are trying to protect and maybe they ve overreacted to something because it s so new.
1
SPEAKER_02
What are your comments on this?
1
SPEAKER_01
So, you know, you hit on a lot of important points.
1
SPEAKER_01
Let s go over a couple of them.
1
SPEAKER_01
First of all, what has completely alarmed everyone
1
SPEAKER_01
is that early prediction that the death rate could be as high as 5%.
1
SPEAKER_01
Remember, 5% means one in 20 people die.
1
SPEAKER_01
It means that more than that actually gets sick, but one in 20 actually die.
1
SPEAKER_01
That means lots of people you know will die, right?
1
SPEAKER_01
you know, point one, New York numbers, it should be 148,000 people.
1
SPEAKER_02
I just read the article based on the original projection.
1
SPEAKER_01
And obviously it s not, but, but influenza deaths, 0.1%, that s one in a thousand.
1
SPEAKER_01
Okay.
1
SPEAKER_01
I bet you that very few of us can remember a friend or loved one who died of influenza.
1
SPEAKER_01
So, so that 5% lethality rate that was originally quoted was the basis for everyone s
1
SPEAKER_01
reflexive and panicked response to this crisis.
1
SPEAKER_01
Now, you mentioned something else which is very important.
1
SPEAKER_01
The data is being derived from numbers based upon certain test results, many of which are not reflective of the biology.
1
SPEAKER_01
And let me explain that.
1
SPEAKER_01
The first test available was a test for the presence of the virus, which is looking for the nucleic acids of the coronavirus itself.
1
SPEAKER_01
They swab the surface of your nasal mucosa.
1
SPEAKER_01
It s not a comfortable thing, but they do it.
1
SPEAKER_01
And then they measure whether or not you have the nucleic acids from this virus.
1
SPEAKER_01
That says you have what s called colonization by the virus.
1
SPEAKER_01
That doesn t equate to infection by the virus.
1
SPEAKER_01
Those are two different things.
1
SPEAKER_01
The only way to determine whether you re really infected is to identify the virus inside you, and you re sick.
1
SPEAKER_01
You re actually developing symptoms.
1
SPEAKER_01
So, if all you re going to do is measure only the people who are symptomatic, and if they re symptomatic, detect virus on them, and that is your case number, that becomes the denominator from which you calculate death rate.
1
SPEAKER_01
So you take the number of people who died over the cases that you discovered, and that s where they were coming up with this 3%, 4%, 5% death rate.
1
SPEAKER_01
That s not an accurate reflection, and it s not the way we calculate the death rate for flu, okay?
1
SPEAKER_01
Just so you know, the CDC, you can go to the CDC website.
1
SPEAKER_01
The CDC calculates the death rate for flu as the number of people who die divided by the estimated number of cases.
1
SPEAKER_01
These are not documented, demonstrated patients who have influenza.
1
SPEAKER_01
It s what the government estimates it to be.
1
SPEAKER_01
I just sent you two graphs.
1
SPEAKER_01
If you look at the first graph, it is the death rate here in the United States, which was starting to drop.
1
SPEAKER_01
The minute it started to drop, it pumped back up.
1
SPEAKER_01
The reason it pumped back up is they started to attribute anyone who died in the hospital as from COVID.
1
SPEAKER_01
You know, that s that s what s called statistical reassignment.
1
SPEAKER_01
Okay, it s a method that s used by people to get whatever they want So if you re going to take someone who got to the hospital and died of a heart attack and then post-mortem Swab his nose and find coronavirus and say hey, he died of covid.
1
SPEAKER_01
That s not that s not accurate, right?
1
SPEAKER_01
You know mark twain said there s three kind of lies lies damn lies and statistics
1
SPEAKER_00
One second here, guys, just to add some context here as well.
1
SPEAKER_00
The important thing for folks to realize is this, again, a pandemic, a viral pandemic, but this is also a pandemic of fear.
1
SPEAKER_00
And it s created by misinformation and by people trying to actually do good, right?
1
SPEAKER_00
Because we don t, we aren t panicking when someone dies from influenza, but let me give some other numbers.
1
SPEAKER_00
We talk about the death rates going on from COVID-19 and we re seeing numbers like
1
SPEAKER_00
you know, peak at 600 a day, 800 a day, 1,000 a day.
1
SPEAKER_00
But here s some numbers to contextualize this.
1
SPEAKER_00
Globally, tuberculosis kills 3,000 people every day.
1
SPEAKER_00
Hepatitis, 2,400 people.
1
SPEAKER_00
You know, HIV, AIDS, 2,100 people.
1
SPEAKER_00
Malaria, 2,000 people.
1
SPEAKER_00
So we have, you know- A day, every single day.
1
SPEAKER_00
Every single day around the world.
1
SPEAKER_00
We re not shutting down every day.
2
SPEAKER_02
everything all over the place and many of those, some of those things are infectious as well.
2
SPEAKER_02
And as bad as this is, again, for all of us, our hearts go out to people and I know friends who have passed on this and who have been intubated on this and it s a terrible challenge.
2
SPEAKER_02
There is one silver lining here that s important to realize.
2
SPEAKER_02
Even, and I ll just say it, I think of this almost as a practice pandemic, in that this is not the first pandemic.
2
SPEAKER_02
There have been massively bad pandemics, and there will be ones in the future, period, as we re encroaching on the environment, as temperatures rise, and all of those elements.
2
SPEAKER_02
We can talk about that if you want.
2
SPEAKER_02
Ultimately, this pandemic could have had the transmissibility that this particular, you know, SARS-CoV-2 virus has with the mortality of an Ebola, right?
2
SPEAKER_02
People treat this like it s a death sentence when they say, oh my God, I have COVID-19.
2
SPEAKER_02
Well, it could be a mild flu, it could be a bad flu, but imagine if it had a 50% mortality rate.
2
SPEAKER_02
And what this practice pandemic has done, and I m going to call that not to diminish the massive financial hardship this has had, but it s uncovered all of the breakpoints in our financial system, our governance system, and our healthcare system, that hopefully, if nothing else, we learn how to repair those and not have that happen again.
2
SPEAKER_02
One other thing that it s doing, and goes to the extraordinary work of my older brother from another mother here, Bob Hurley, is it s causing and allowing the FDA to iterate faster.
2
SPEAKER_02
Because we ve had a very slow, methodical,
2
SPEAKER_02
you know, it s a bureaucracy.
2
SPEAKER_02
And we are seeing, you know, again, diagnostics and vaccines, we ll talk about that in part two of this, but also antivirals and also therapeutics, one of which, very proud, is the brainchild of Bob Hurley.
2
SPEAKER_00
The piece that we re trying to get across to you is that, yes, this is serious, but so is the flu, and that the people that are most affected by the flu are also the elderly.
2
SPEAKER_00
If you look in Italy and see all these people dying, 79% of them have died or over 90, right?
2
SPEAKER_00
Literally 99% of the people who have the disease have some preexisting condition, and more than half have three, cancer, heart disease, diabetes.
2
SPEAKER_00
And Bob, maybe you can mention about what s been happening, because let s put up what the Nobel Prize winner said from Stanford, just so you know.
2
SPEAKER_00
He was talking about, he s been on the air talking about this.
2
SPEAKER_00
He said, we re trying to do modeling, we re trying to look at numbers, and we re trying to understand what they re telling us.
2
SPEAKER_00
One problem with these tests is they re very sensitive.
2
SPEAKER_00
Small amounts, he shared with us, tiny amounts of the virus can be detected.
2
SPEAKER_00
So almost everyone who dies, no matter what the cause, will have coronavirus, but that s not the reason it killed you.
2
SPEAKER_00
It didn t kill you.
2
SPEAKER_00
You could have died in a car accident and be having it.
2
SPEAKER_00
So he s arguing that we ve overreacted.
2
SPEAKER_00
We shut down our economies based on those 5% projections, which aren t even true.
2
SPEAKER_00
Fauci himself is saying it s less than 1%.
2
SPEAKER_00
Maybe it s the same as the flu.
2
SPEAKER_00
But we ve now built an entire system of destruction of the economy.
2
SPEAKER_00
People are so afraid because they don t know what the real facts are.
2
SPEAKER_00
And I saw on one day in February where the death rate jumped 600 percent in a day.
2
SPEAKER_00
I m like, you know, I m not a genius virologist, but I know it s pretty hard for something to jump that much in a day.
2
SPEAKER_00
And so we went through the statisticians and Bob, I know you can comment on this because you ve seen it.
2
SPEAKER_00
They changed the rules on how they diagnosed.
2
SPEAKER_00
You used to have to have a test to say you died of it.
2
SPEAKER_00
And they might put in the notes that, you know, they had symptoms or it was probable that it may have been brought on by COVID or the flu.
2
SPEAKER_00
Now, they just count, they don t need any tests and they count it.
2
SPEAKER_00
So the numbers you re seeing that even seem high, they re not high in deaths.
2
SPEAKER_00
But even the death rate is not probably a fair representation.
2
SPEAKER_00
And Bob, maybe you can address that, the sensitivity of this.
2
SPEAKER_00
Because the other thing we found is there s an article from 2014 and the title is Where Did SARS Go?
2
SPEAKER_00
And the description is it s a coronavirus and that some colds and flus are driven by it.
2
SPEAKER_00
And that, you know, over time, two thirds of us will end up having it.
2
SPEAKER_00
But as you said, Bob, we ll feel nothing or we ll have mild symptoms that the
2
SPEAKER_00
The people that are affected by it are those whose immune systems are compromised, which we re going to get to with you, Bob, with a solution.
2
SPEAKER_00
But those are compromised because of pre-existing conditions.
2
SPEAKER_00
And before, they would say they died of pneumonia, or they died of cancer, or they died of whatever.
2
SPEAKER_00
But now it s being pushed to, it s a COVID death.
2
SPEAKER_00
So can you address that, Bob?
2
SPEAKER_00
Because you re in New York in the hospitals, and you re sharing with me what you ve seen.
2
SPEAKER_01
So, you know, Professor Levitt is a brilliant scientist in his own right, but he s also very practical and reasonable.
2
SPEAKER_01
reality is what he is saying is true.
2
SPEAKER_01
You can create statistics that will fit any narrative.
2
SPEAKER_01
One does not realize upfront, but the panic that was created because of the forecasted lethality of this virus
2
SPEAKER_01
meant that people were flooding hospitals and overwhelming the healthcare system.
2
SPEAKER_01
What we were supposed to not do, remember, flatten the curve, flatten the curve, don t ever exceed the carrying capacity of the hospital.
2
SPEAKER_01
But by instilling that panic, people went to hospitals.
2
SPEAKER_01
And by the way, the people who went to the hospital and got sent home,
2
SPEAKER_01
spent 12 to 16 hours sitting in a place that was awash with more coronavirus, right?
2
SPEAKER_01
And so if you happen not to have had a big inoculum before, you spend 12 hours in the ER and you re going to go home with it.
2
SPEAKER_01
And you re going to spread it around even more.
2
SPEAKER_01
The truth of the matter is that what concerns me is that it appears that rather than take
2
SPEAKER_01
a conservative look at the numbers and provide true realistic data and explain how you arrive at these numbers.
2
SPEAKER_01
There were times when people were saying the lethality rate may be higher than 5%.
2
SPEAKER_01
Look, I m a father.
2
SPEAKER_01
I ve got kids.
2
SPEAKER_01
You can imagine what would happen after you heard that news and your kid starts coughing.
2
SPEAKER_01
You don t know if you re able to detect whether it s serious or not.
2
SPEAKER_01
So you go to the expert.
2
SPEAKER_01
When those experts are overwhelmed in a hospital,
2
SPEAKER_01
That s not a good thing.
2
SPEAKER_01
When those experts, overwhelmed in the hospital, every time a patient starts to have evidence of these respiratory problems, they re in the ICU.
2
SPEAKER_01
And then what we call the threshold for intervention, the threshold for intervention comes down, because you don t want people dying.
2
SPEAKER_01
The docs and the nurses in the hospital are absolute heroes.
2
SPEAKER_01
The minute they see somebody starting to crash, they go all out and they re putting these patients on ventilators.
2
SPEAKER_01
Now we re learning that the ventilators may in fact be contributing to the problem because it s not a conventional pneumonia.
2
SPEAKER_01
We didn t give ourselves time to figure this stuff out, okay?
2
SPEAKER_01
So picture this, 100 people hit the ER, 80 of them are well enough to go home.
2
SPEAKER_01
That means their immune system s doing its job.
2
SPEAKER_01
There s probably a thousand people who are have carried it.
2
SPEAKER_01
So a thousand get it get carry it a hundred wind up Being infected with it of that hundred eighty percent immune system is good enough to send them home of the of the twenty that are left over
2
SPEAKER_01
15 or so can be managed in the hospital with relatively conservative measures, some supplemental oxygen, some antibiotic support, et cetera.
2
SPEAKER_01
And those people never have to go to the ICU or get ventilated.
2
SPEAKER_01
Five of them, five to six of them, wind up having to go to the ICU and get on a ventilator.
2
SPEAKER_01
And the reason that they go downhill is because the virus induces a very
2
SPEAKER_01
very aggressive immune response and inflammatory response, which basically prevents the oxygen from getting across their lungs.
2
SPEAKER_01
If any of you guys follow my Twitter, you may have noticed I said a few days ago that when I look at the data, these patients actually look more like they re at altitude.
2
SPEAKER_01
Their lungs are acting more like they re at the top of the Himalayas than they are having a pneumonia.
2
SPEAKER_01
And what that means is there s a problem getting oxygen across the lung into the bloodstream.
2
SPEAKER_01
Now, that s interesting because it changes a little bit of the strategy, the ventilator strategy, but it may also mean that the virus is doing something very unconventional, okay, which means that it may be damaging lung tissue irreversibly, and this may in fact be the reason why many people who survive this still have longstanding cardiac and pulmonary problems.
2
SPEAKER_00
I ve just one quick question that may not be interesting for anybody else, but I m curious.
2
SPEAKER_00
I haven t seen your blog about this, but I ve also read about the oxygen thing, and there s several doctors saying the pressure that s being done in these hospitals, they need just the oxygen, not just the pressure, that the pressure actually may be doing more damage.
2
SPEAKER_00
Is that right?
2
SPEAKER_00
Yes.
2
SPEAKER_00
Thank you.
2
SPEAKER_01
You re so right, Tony.
2
SPEAKER_01
Here s the thing, right?
2
SPEAKER_01
I ve treated 1,500, 2,000 pneumonias in the ICU in my days, okay?
2
SPEAKER_01
Pneumonias are very different.
2
SPEAKER_01
The lung literally gets filled up with pus.
2
SPEAKER_01
Literally, bacteria and other microorganisms colonize and create a
3
SPEAKER_02
create an inflammatory response, and the lungs literally get filled up with fluid and gunk and everything else.
3
SPEAKER_02
In those patients, you have to create very high airway pressures to get air down into the bronchiole so people can get oxygen.
3
SPEAKER_02
This is different.
3
SPEAKER_02
In fact, you don t need high airway pressures.
3
SPEAKER_02
In fact, you re right, it probably is deleterious.
3
SPEAKER_02
Okay, that to me suggests that the mechanism on the lung is very, very different.
3
SPEAKER_02
And it suggests that any stem cell product capable of modulating the immune response and stimulating regeneration is probably really going to be very, very good.
3
SPEAKER_00
I think the great news about it is it brings people s attention to studying the immune system because that s the real factor.
3
SPEAKER_00
I was reading in Italy, 79% of the patients that died in Italy over the age of 90
3
SPEAKER_00
That s the current number.
3
SPEAKER_00
And also, influenza has been growing like crazy.
3
SPEAKER_00
25,000 people die of the flu there normally.
3
SPEAKER_00
So you ve got the oldest population in the world other than Japan, and you have this mass rush that s been generated by the media and fear.
3
SPEAKER_00
People, like you said, coming to the hospital, using all the resources, and they don t need anything.
3
SPEAKER_00
But the media has created so much fear.
3
SPEAKER_02
And you know, it s sort of like, we ve all been through it, right?
3
SPEAKER_02
Tony, where you live, a hurricane s brewing in the Bahamas, okay?
3
SPEAKER_02
And you re told it s going to be the worst hurricane in the history of your part of Florida.
3
SPEAKER_02
And what does everybody do?
3
SPEAKER_02
They run out and they tear apart every store.
3
SPEAKER_02
You can t get a gallon of milk.
3
SPEAKER_02
You can t buy a loaf of bread.
3
SPEAKER_02
And then what happens
3
SPEAKER_02
It comes and sweeps by, everybody s fine, and what you ve done is you ve bruised the system for the foreseeable weeks ahead.
3
SPEAKER_02
Now, in this case, listen, I would never want to be in Dr. Fauci s shoes, right?
3
SPEAKER_02
You have this thrown on your shoulders, and his greatest fear is, if I under-inform people, are people going to die unnecessarily?
3
SPEAKER_02
I think it was unfair to leave this all on the shoulders of one guy.
3
SPEAKER_02
What they should have done, since this is a mass casualty scenario, they should have enlisted multiple experts.
3
SPEAKER_02
They should have gotten
3
SPEAKER_02
trauma docs who deal with mass casualty stuff.
3
SPEAKER_02
They should have gotten more than just epidemiologists.
3
SPEAKER_02
They should have gotten intensivists and others who understand the practical nature of deploying care and said, hey, guys, what should we really be telling the public?
3
SPEAKER_02
Because I guarantee it would have been a more tempered type of description.
3
SPEAKER_02
Now, right now, what we know is this.
3
SPEAKER_02
It is far less lethal than originally predicted.
3
SPEAKER_02
It is a rapidly transmittable disease, but since most people have mild disease, it means most people are gonna just kind of go through this.
3
SPEAKER_02
And guess what?
3
SPEAKER_02
Guess what happens after they get through it?
3
SPEAKER_02
They come out immune, right?
3
SPEAKER_02
Or probable immune.
3
SPEAKER_02
So what we re doing to some extent by isolating everyone is we re slowing the development of community immunity to the disease.
3
SPEAKER_02
And community immunity is important going forward.
3
SPEAKER_02
That s what prevents the thing from coming back in the fall.
3
SPEAKER_02
It also means that we have completely taxed the healthcare system, so they no longer have a big reserve left if something really bad was to happen.
3
SPEAKER_02
I think
3
SPEAKER_02
None of us are critical of anyone, but we do believe that we can learn lessons here.
3
SPEAKER_02
And these lessons should never let us go back to this again.
3
SPEAKER_02
And by the way, when people say the cure can t be worse than the disease, you know, we have no idea how to calculate the impact of poverty and joblessness and depression.
3
SPEAKER_02
I mean, you know, by the way, what happens to somebody in solitary confinement in prison?
3
SPEAKER_02
right?
3
SPEAKER_02
They get sick.
3
SPEAKER_02
Okay.
3
SPEAKER_02
It s one of the most stressful things you can put people through.
3
SPEAKER_02
Isolation is causing, is causing unknown amounts of health problems that we are going to have to deal with going forward.
3
SPEAKER_02
And you know, it s very sad because I remember the beginning of the year,
3
SPEAKER_02
seeing optimism and joy and a sense of a willingness to go out and take risks in building businesses.
3
SPEAKER_02
In my community, people were opening stores and restaurants, and now these people are boarding them up.
3
SPEAKER_02
What s going to happen?
3
SPEAKER_01
We re going to have more bankruptcies, more unemployment, and it s truly a massive impact.
3
SPEAKER_01
And
3
SPEAKER_01
Honestly, when this is said and done, I don t think we re gonna have properly measured that.
3
SPEAKER_01
And the challenge is gonna be, how do we revitalize?
3
SPEAKER_01
It takes a while, it takes years after three or four months of impact to bring the economies back.
3
SPEAKER_01
The virus is not going away, right?
3
SPEAKER_01
The virus is still gonna be the environment.
3
SPEAKER_01
No, no, no, it s gonna be part of the environment forever.
3
SPEAKER_00
Exactly.
3
SPEAKER_00
And it may have already been, it could have been here before six months ago.
3
SPEAKER_00
Like we re reading this piece on coronaviruses from six years ago, they said we d have two thirds of us would have it.
3
SPEAKER_00
So it s, we re, there s a lot of assumptions that we re making along the way with science that needs to have assumptions that are tested, but we didn t test them in this environment.
3
SPEAKER_00
We made those assumptions.
3
SPEAKER_00
We ran our algorithms and we went again.
3
SPEAKER_00
Nobody had bad intent.
3
SPEAKER_00
all these politicians committing, you know, an emergency when there s one death in the state, they re just being told by everybody else, this is what s going to grow to.
3
SPEAKER_00
I saw the governor of Ohio call a declaration of emergency and he said, we re going to have 100,000 people infected here.
3
SPEAKER_00
And then, you know, one intelligent reporter said there s only 1120 infections in the whole country right now.
3
SPEAKER_00
How can you say 100,000 in your state?
3
SPEAKER_00
And he said, well, it s going to double from 100,000 in a few weeks.
3
SPEAKER_00
And we re gonna have all these deaths. 
3
SPEAKER_00
And so he said, well, I ve been told that by the experts.
3
SPEAKER_00
He put his expert on, a doctor, a really great lady.
3
SPEAKER_00
And she apologized, says, I was really exhausted this morning when I made these predictions.
3
SPEAKER_00
She literally says this on the air.
3
SPEAKER_00
And then she said afterwards, but other experts have been telling me it s about 1% and it ll keep doubling.
3
SPEAKER_00
So we have made these decisions that now it s gonna be hard not to do.
3
SPEAKER_00
They all came from the best intent, protect our people.
3
SPEAKER_00
but we re getting to the real numbers.
3
SPEAKER_00
They re a bit challenging.
3
SPEAKER_00
So how do you explain a place like Sweden that s got a population like that and they don t, that s not out of control and they re not doing what we re doing here.
3
SPEAKER_00
Schools are open.
3
SPEAKER_00
Primary schools are open.
3
SPEAKER_00
Preschools are open with little children.
3
SPEAKER_00
Restaurants are open.
3
SPEAKER_00
People in the streets.
3
SPEAKER_02
Yeah.
3
SPEAKER_02
I mean, listen, there, there were two approaches to this, right?
3
SPEAKER_02
One approach upfront was to understand the possible
3
SPEAKER_02
bad side of this virus and calculate the worst case scenario, present it like that, but deal with it as mid case or best case scenario, right?
3
SPEAKER_02
And take conservative measures.
3
SPEAKER_02
For example, you just pointed out the vast majority of people who do very poorly are the very old or the ones with comorbidities.
3
SPEAKER_02
So right off the bat,
3
SPEAKER_02
selective isolation of the high risk groups might ve been a more conservative measure.
3
SPEAKER_02
Now, are younger people getting sick and dying?
3
SPEAKER_02
Yeah, absolutely.
3
SPEAKER_02
But the reality is the way you approach a crisis like this is either, it s either hysteria or rational or rational thinking.
3
SPEAKER_02
And it s very sad.
3
SPEAKER_02
I don t, I don t blame Dr. Fauci.
3
SPEAKER_02
I do blame the media.
3
SPEAKER_02
I do blame the media because as Peter taught me, you know,
3
SPEAKER_02
People are designed to pay 10 times more attention to bad news than good news.
3
SPEAKER_02
And so you give the media a little bit of bad news and they run with it.
3
SPEAKER_02
Okay.
3
SPEAKER_02
And they sit there and they, and they wallow in, in the panic they create.
3
SPEAKER_02
You know why?
3
SPEAKER_02
Because the more panic they create, people won t change the channel, right?
3
SPEAKER_02
They ll stay and they ll listen.
3
SPEAKER_02
So, so the truth of the matter is we did a disservice to the public by, by not fully informing them.
3
SPEAKER_02
on how the numbers were arrived at, letting other experts opine.
3
SPEAKER_02
I hate when just one person is the sole source of information, right?
3
SPEAKER_02
We need to engage a lot of other folks.
3
SPEAKER_02
And by the way, there are people who try to get the word out and they re suppressed.
3
SPEAKER_00
Let s look at one other thing.
3
SPEAKER_00
They chatted them down towards some of the solutions, as you know, Bob.
3
SPEAKER_00
And I m not here to attack the media either.
3
SPEAKER_00
I think the media is trying to do its job, but they re no longer designed to inform us.
3
SPEAKER_00
It s too competitive.
3
SPEAKER_00
Now they ve got to startle us.
3
SPEAKER_00
And the only thing that startles us is something huge.
3
SPEAKER_00
And so they also believe it.
3
SPEAKER_00
They re not asking the questions, OK, we have this many cases.
3
SPEAKER_00
How many are actually hospitalized?
3
SPEAKER_00
Or how does this compare to flu deaths?
3
SPEAKER_00
None of those questions are being asked.
3
SPEAKER_00
It s just full force.
3
SPEAKER_00
It gets all the attention.
3
SPEAKER_00
And now there are people that they ve heard it for week after week, day after day, that it s like religion to them.
3
SPEAKER_00
They pretended science, but they say people are dying or you re promoting people, you know, doing things that are dangerous if you inform people that the numbers are different than they are.
3
SPEAKER_00
That s just not true.
3
SPEAKER_00
So let s move into
3
SPEAKER_00
You know, what are the things that we do?
3
SPEAKER_00
There s lots of great solutions that are showing up right now for someone who is in a severe situation, usually with other challenges, as you ve already pointed out, of pre-existing conditions.
3
SPEAKER_00
Let s talk about the solutions, and then, Bob, let s see if we can t give people just a little bit of history about cellular medicine, all the way back to where you re kind of the father of it, to some extent, because of the research you did with the rats 30 years ago.
4
SPEAKER_00
Let s pick which direction everyone you want to grab first.
4
SPEAKER_00
Let s move in that direction now.
4
SPEAKER_00
Hopefully, if you re listening, we ve got you at least the question that it isn t as severe, extreme thing as you think.
4
SPEAKER_00
And it doesn t have to be in your life that way.
4
SPEAKER_00
If you understand the numbers, you still want to do things that take care of yourself.
4
SPEAKER_00
But 90% of the people plus are not at severe risk.
4
SPEAKER_00
And the numbers are tiny in context for everything else that happens.
4
SPEAKER_00
Right now, 1.35 million people will die this year in a car accident around the world.
4
SPEAKER_00
It s 3,200 people a day.
4
SPEAKER_00
None of us are saying, people cause these car accidents, right?
4
SPEAKER_00
There s a little yellow line, someone s driving 70 miles an hour, you re going there, and we know every day, somebody s gonna fall asleep, somebody s gonna be texting, someone s gonna be drunk, and they come over and kill people every day, 3,200 a day.
4
SPEAKER_00
But we don t say we re never going to drive again.
4
SPEAKER_00
Let s put a moratorium on driving.
4
SPEAKER_00
And why do we drive?
4
SPEAKER_00
How do we drive?
4
SPEAKER_00
Knowing that someone can kill us every day.
4
SPEAKER_00
It could happen any moment.
4
SPEAKER_00
We do it by using faith, not a religious term, just we re born with a faith that says, if I don t create certainty in myself, in spite of all the things that are risky, I have no life.
4
SPEAKER_00
I have to stay home and not move, which is kind of what we re doing right now.
4
SPEAKER_00
So let s talk about either some of the solutions, but maybe first before the solutions, let s talk about cellular medicine for a moment and your original studies and what you found, because this goes way beyond COVID.
4
SPEAKER_00
We re going to talk about COVID-19 and your solutions, but it really is the breakthrough that s happening in regenerative medicine.
4
SPEAKER_00
It s probably the most powerful change in medicine that s happened in a century.
4
SPEAKER_01
The other thing to contextualize this again is if you feel like
4
SPEAKER_01
COVID-19 is going away and it s not as bad as it is.
4
SPEAKER_01
Again, remember, this is one of many pandemics.
4
SPEAKER_01
One of the questions that we re going to be asking Bob to address here is
4
SPEAKER_01
How do we prevent this from happening again?
4
SPEAKER_01
How do we actually put in place the mechanisms to keep us safe?
4
SPEAKER_01
And one thing that we did learn from all this data is, you know, 100 to one older people are dying than younger people.
4
SPEAKER_01
It s not that the virus understands a person s age, it s that we understand your immune system.
4
SPEAKER_01
We re constantly being infected by viruses, by cancers, and your immune system is an incredible defense system.
4
SPEAKER_01
that protects all of us from it.
4
SPEAKER_01
But as we age, as you ll hear, our immune system starts to degrade.
4
SPEAKER_01
And one of the incredible pieces of vision and work that Bob s been doing is how do we augment our immune system?
4
SPEAKER_01
So listen to what Bob says from the perspective of hope, not just for this situation, but to protect us in the decades to come.
4
SPEAKER_00
And also not just from viruses, but also what to do to regenerate and rejuvenate your whole body.
4
SPEAKER_00
This doesn t have to be a survival issue.
4
SPEAKER_00
We have science today that can make you younger, stronger, more effective than before.
4
SPEAKER_00
You know, we re working on a book together on this whole regenerative medicine breakthroughs that are there.
4
SPEAKER_00
So Bob, just so people have context, let s shift to something that s a bit more uplifting.
4
SPEAKER_00
Hopefully people are uplifting to say it s not as bad as we thought.
4
SPEAKER_00
Still got to deal with the economic consequences.
4
SPEAKER_00
We re doing separate events on that, seminars for people.
4
SPEAKER_00
tell how to get their business going again as the world shifts.
4
SPEAKER_00
But let s talk about how you got on this road.
4
SPEAKER_00
I mean, you re a neurosurgeon, you ve got amazing background, but tell us what you did with rats about 30 years ago that kind of started this journey.
4
SPEAKER_02
Well, you know, Tony, 30, 35 years ago, back when I was a
4
SPEAKER_02
Working on my PhD at Cornell, one of the areas I was very interested in was the development of vascular disease.
4
SPEAKER_02
And I was looking at the differences between old and young animals and why old animals develop much worse vascular disease than young animals.
4
SPEAKER_02
And I was transplanting blood vessels from old and young and young and old.
4
SPEAKER_02
And it turned out that if I put an old blood vessel in a young animal, the old blood vessel was rejuvenated.
4
SPEAKER_02
It acted young again.
4
SPEAKER_02
And I didn t know it at the time, but I was doing a stem cell experiment back then.
4
SPEAKER_02
I was actually allowing the blood vessel to be renovated and remodeled by the stem cells coming from the young environment.
4
SPEAKER_02
Now, fast forward over 25 years ago, I got interested as a doctor taking care of head and spinal cord injury.
4
SPEAKER_02
I got very interested in the emerging field of stem cell biology because I saw it as a potential tool to restore function in brain injured and spinal cord injured patients.
4
SPEAKER_02
At the time, most of the work was focused around using cells from embryos.
4
SPEAKER_02
I recognized that for stem cells to have a meaningful place in medicine, someone was going to have to productize them.
4
SPEAKER_02
Someone was going to have to turn them into a pharmaceutical-like product that a doctor could write an order for and apply a dose just the way they do any other therapeutic.
4
SPEAKER_02
It was at that time my oldest daughter was in utero and as a young surgeon coming down to look at the first ultrasound, something dawned on me that hadn t in the past, which was although she was a peanut-sized embryo, the placenta was already this big organ.
4
SPEAKER_02
And it dawned on me with a little bit of knowledge of stem cells and where they come from and a little bit knowledge of the physiology of the placenta, it turned out that I was convinced the placenta must play a role
4
SPEAKER_02
as the source of stem cells, which participated in the development of my unborn child.
4
SPEAKER_02
Now, that got me interested enough to go look and chase it, and what happened was we found that the placenta was, in fact, nature s stem cell factory.
4
SPEAKER_02
At a time when you had to either destroy an embryo or harvest the leftovers of an abortion,
4
SPEAKER_02
Every birth yields a waste product called the placenta that s incinerated, has to be disposed of, but it was a great source of these biologic materials.
4
SPEAKER_02
I started a company around that concept.
4
SPEAKER_02
That company soon identified that the placenta was a source of cells that could replace any other source of stem cells, and it turned into what was the fastest growing player in the cellular medicine space.
4
SPEAKER_02
Today, that company, Cellularity, was spun off of its parent company, Cellgene, and now we have the largest portfolio of cellular medicines in the world.
4
SPEAKER_02
But what s interesting is we re using the fundamental native biology of those stem cells, their unique universal donor characteristics, meaning that the placenta is a source of cells that could be administered to anyone without having to match them, and the placenta has unique
4
SPEAKER_02
defense capabilities in protecting the developing fetus from things like cancer or infectious diseases.
4
SPEAKER_00
Would you make a note?
4
SPEAKER_00
For everyone to know, what Bob told me has blew my mind.
4
SPEAKER_00
There is no situation, correct me if I m wrong, Bob, where a mother with cancer is transferred to her baby.
4
SPEAKER_00
That s how powerful the placenta is.
4
SPEAKER_00
Is that correct?
4
SPEAKER_02
It s so rare that it becomes an isolated report.
4
SPEAKER_02
The placenta defends the fetus from anything which would cause its demise.
4
SPEAKER_02
If you think about it, human beings devote nine months of reproductive energy to one offspring.
4
SPEAKER_02
Evolution has selected for capabilities that protect that offspring at all costs.
4
SPEAKER_02
Because back when humans were living 25, 30 years, you didn t get a lot of shots at producing babies to replace yourself.
4
SPEAKER_02
And so that remarkable ability is conserved and transferable in the cellular products.
4
SPEAKER_02
Among those unique properties, this ability for part of the immune system of the placenta and the newborn to actually defend against the transmission of cancer and infectious diseases was something we were fascinated by.
4
SPEAKER_02
We studied and we identified a unique natural killer cell.
4
SPEAKER_02
A natural killer cell is a specialized part of the immune system that is pre-programmed, if you will, to destroy potentially threatening
4
SPEAKER_02
cells, whether they re cancer cells or bacteria or fungus or viruses or whatnot.
4
SPEAKER_02
Turns out that these placental natural killer cells target antigens, molecules that get expressed on the surface of cancer cells and virally infected cells.
4
SPEAKER_02
in the midst of our clinical trials in cancer, the COVID-19 crisis erupted.
4
SPEAKER_02
And although we always thought of the possibilities of taking these NK cells into infectious diseases, we saw an urgency to develop them for that purpose.
4
SPEAKER_02
We did the underlying scientific work,
4
SPEAKER_02
filed an investigational new drug application with the FDA, have been granted permission to test this in patients, and we re out treating patients as we speak, Tony, with COVID-19 with these placental NK cells.
4
SPEAKER_01
So we re very excited about that.
4
SPEAKER_01
What does treatment mean?
4
SPEAKER_01
What happens to a patient and what level is this?
4
SPEAKER_01
You re treating patients through an intravenous transfusion of these natural killer cells to basically augment the natural killer cells they have in their current bloodstream.
4
SPEAKER_01
How sick are the patients you re likely to treat?
4
SPEAKER_01
And then can you speak to the fact that this will be a therapy that can be on standby
4
SPEAKER_01
any place on the planet at any time it s needed.
4
SPEAKER_00
And just along with that, Bob, if I can add on there, let people know that in China, most people don t know the people that they re the most sick, those people in their 80s and 90s.
4
SPEAKER_00
This is one of the only treatments, am I correct, that was successful in turning those people and getting them back out of the hospital?
4
SPEAKER_00
Maybe a little background on that and then tell us how you re treating them now.
4
SPEAKER_02
So there are very promising reports out of
5
SPEAKER_02
China in patients with serious COVID-19, including patients who are on ventilators, that cell therapy has worked.
5
SPEAKER_02
Let me preface things by saying this.
5
SPEAKER_02
Cellular therapy as a way to augment or support or boost the immune response is a revolution in the treatment of cancer, okay?
5
SPEAKER_02
We now know we can take immune cells, engineer them to turn up some of their capabilities to target tumors, and they re very, very effective at supporting a patient s response against that particular malignancy.
5
SPEAKER_02
I believe the same will apply in treating infectious diseases.
5
SPEAKER_02
And as Peter pointed out, what we re really doing here is we re boosting and supporting a patient s dysfunctional or deficient immune response by giving them reinforcements in the form of these NK cells from donor placentas that are produced in our manufacturing facility.
5
SPEAKER_02
The nice thing about this is it s administered via simple intravenous infusion.
5
SPEAKER_02
Putting an IV in can be done in an emergency room.
5
SPEAKER_02
It can be done in an infusion clinic.
5
SPEAKER_02
It can be done literally in a doctor s office.
5
SPEAKER_02
And the beauty is these cells boost.
5
SPEAKER_02
They supplement your own body s immune response to a disease, which makes it a very convenient and clinically deployable methodology that fits into pretty much any health care system.
5
SPEAKER_02
Now, the nice thing about getting these cells out of the postpartum placenta, this waste material,
5
SPEAKER_02
is it s a it s an approach that s both scalable and ultimately will have economics that are not going to be destructive to the health care system.
5
SPEAKER_00
Okay explain explain a little bit why Bob in terms of the amount you can utilize these how you can do this people be saying how many placentas are being donated to make this happen can you explain just for a second before you go on so they know why it s really scalable and why the cost can be a lot less than a lot of the treatments certainly a lot less than traditional cancer treatments.
5
SPEAKER_02
So cellularity has pioneered the ability to, um, what we call culture, expand and mass produce cells from the placenta, which means that from one placental donor, we can produce many doses of cells for different therapeutic purposes.
5
SPEAKER_02
Keep in mind in the world today, 130 million placentas, 130 million placentas are disposed of every year.
5
SPEAKER_02
They re, they re waste material.
5
SPEAKER_02
So it s kind of an inexhaustible raw material.
5
SPEAKER_02
And since you can produce multiple doses from one placenta, you know, we don t see that as being a rate limiter to deliver therapies for these sorts of diseases.
5
SPEAKER_02
And because cellularity, like other companies in cellular medicine, recognize that at the dawn of our industry,
5
SPEAKER_02
the manufacturing process is as much the product as the cells.
5
SPEAKER_02
We re getting better and better and better at creating efficiencies and quality systems so that these cells can be produced with very attractive economics.
5
SPEAKER_01
Bob, let me inject one thing that s very important.
5
SPEAKER_01
I think if anybody who s listening, if you re pregnant or you know someone who is pregnant,
5
SPEAKER_01
Right now, one of the things I think is almost a moral and ethical obligation is for you to bank your placenta.
5
SPEAKER_01
We ve heard about cord blood banking, where you take umbilical cord blood and it s frozen.
5
SPEAKER_01
And if you ever should have a hemopoietic cancer, leukemia or something, that child
5
SPEAKER_01
you can use radiation to wipe out their existing bone marrow and replenish it from their original bone marrow.
5
SPEAKER_01
But even better than that is the ability to keep the placental cells, both in this case, the stem cells, which are pluripotent, not at this moment yet, but in the near future, we re going to be able to regrow
5
SPEAKER_01
organs, liver, lungs, kidneys, hearts.
5
SPEAKER_01
So I have two nine-year-old boys.
5
SPEAKER_01
Nine years ago, I banked the cells from their placentas.
5
SPEAKER_01
The company is a division of Cellularity.
5
SPEAKER_01
And full disclosure, I m a co-founder, vice chairman of Cellularity.
5
SPEAKER_01
And Tony is an investor in the company.
5
SPEAKER_01
Just make sure everybody knows that.
5
SPEAKER_01
But it s called Life Bank USA.
5
SPEAKER_01
And it s a process that is simple and easy.
5
SPEAKER_01
And I just think it s something that most people don t know about.
5
SPEAKER_01
And if they did, they d bank their placental cells.
5
SPEAKER_00
What we re really talking about is how to use a natural material created by God, the universe, whatever you want to call it, to stimulate the immune system to get back to its healthy form again.
5
SPEAKER_00
And so, as we said earlier, you ve got cancer cells in your body right now, but you don t have cancer because your immune system is working well.
5
SPEAKER_00
You know, you ve got streptococcus germs in the back of your throat, you don t have strep throat.
5
SPEAKER_00
You gotta have COVID-19 in really tiny amounts like we re seeing and not seeing it in your immune system is fine.
5
SPEAKER_00
It s also why, even though today we re seeing cancers and diseases like this in young people as well, the majority, Bob, you can approach or mention about this, are happening older.
5
SPEAKER_00
These are age-old diseases.
5
SPEAKER_00
Now, we re doing things that are suppressing immune systems, even children today.
5
SPEAKER_00
But as you age, the immune system starts to get down.
5
SPEAKER_00
So we re sending the information in not just to deal with a COVID-19 or to deal with a cancer, but also some people are doing it as a preparation for their nervous system to stay at its peak before any of these challenges happen.
5
SPEAKER_00
True, Bob?
5
SPEAKER_02
So the reality is that no placenta should go to waste.
5
SPEAKER_02
We have the ability to process and derive cells from the placenta and mass produce them.
5
SPEAKER_02
And the beauty is that cells can be cryopreserved, put in liquid nitrogen, and they can be available decades later.
5
SPEAKER_02
and they can still have value many decades later.
5
SPEAKER_02
So I m with you guys.
5
SPEAKER_02
I think it s one of the great resources and the opportunity to collect and process and bank is a great thing.
5
SPEAKER_02
More importantly is every placenta, even if it s donated, can be the source of material to produce life-saving products like the ones we re talking about.
5
SPEAKER_02
But to get back to the really the kind of the heart of what we re talking about today,
5
SPEAKER_02
Cellular immunotherapy as a way to treat and defeat viral infections
5
SPEAKER_02
I believe we are going to be able to demonstrate that this is a rational, logical way to go about supporting patients like COVID-19 patients.
5
SPEAKER_02
Hopefully, COVID-19 is a self-limited problem, and we ll be beyond this very shortly.
5
SPEAKER_02
But as Peter pointed out, if this is a practice pandemic, we need to have tools available instantly if this ever rears its ugly head again.
5
SPEAKER_02
and it may rear its ugly head as a reappearance of the same virus, as the appearance of a mutated version of the virus, or a brand new novel virus that may have worse characteristics than this one.
5
SPEAKER_02
That being said, cellular immunotherapy, because
5
SPEAKER_02
virtually all virally infected cells are targetable because they all express very similar molecules that make them visible to these natural killer cells might be the one size fits all approach to dealing with these types of pandemics.
5
SPEAKER_02
We have to do the work to prove it, but it s extremely promising, and we believe it s very much worthy of the work that s going on right now to create unequivocal data in support of it.
5
SPEAKER_00
Maybe the silver lining in all of this is to see that the FDA and everyone is having to open up to new things, and it may speed up the capacity for cellular therapy to be really maximized, measured, and utilized, so we don t just prevent what happens in the future, but we continue to make people healthier along the way on the normal path of life.
5
SPEAKER_02
And Tony, I think the three of us recognize that there s always a solution to a problem.
5
SPEAKER_02
And rather than throw your hands up and surrender because the problem appears to be beyond our current capabilities, I believe we have to enlist the ingenuity and innovativeness and inventiveness of this great country to solve the problem.
5
SPEAKER_02
We re already seeing
5
SPEAKER_02
that great innovations are putting a dent in this disease.
5
SPEAKER_02
Let me bring one thing up.
5
SPEAKER_02
Hydroxychloroquine, okay?
5
SPEAKER_02
I mean, let s face it, okay?
5
SPEAKER_02
A smart doctor who s very, very skilled in treating infectious diseases just was a good observer.
5
SPEAKER_02
You know, he recognized that this particular drug, which is a generic drug, it costs virtually nothing.
5
SPEAKER_02
It s been around for 50, 60 years.
5
SPEAKER_02
It s been used in tens of millions of people.
5
SPEAKER_02
It just turns out that it was effective in his observation at reducing the time these patients were sick and getting them off ventilators.
5
SPEAKER_02
So he brought it up and he combined it with an antibiotic and the results appeared to be even better.
5
SPEAKER_02
Now, first and foremost,
5
SPEAKER_02
That single observation at the early part of this crisis should have been celebrated, okay?
5
SPEAKER_02
And it should not have been dismissed as, well, there s no double-blinded, placebo-controlled studies
6
SPEAKER_02
that prove that it works.
6
SPEAKER_02
Listen, here s the bottom line, okay?
6
SPEAKER_02
That observation by itself could have been the source of a cooperative effort to tease out what was really at play here.
6
SPEAKER_02
So let me give you a couple of add-ons behind all this, all right?
6
SPEAKER_02
It turns out that go look at an international map of the incidence of COVID-19.
6
SPEAKER_02
It s very striking that in certain zones of the world, there s a very, very horrifically low incidence of the disease.
6
SPEAKER_02
It just turns out that those are the malaria prone countries.
6
SPEAKER_02
And it just turns out that many people in those countries are on these medications chronically.
6
SPEAKER_02
Okay, that was a little data chunk, a little factoid that should have been stored away.
6
SPEAKER_02
The other factoid was that people who have lupus, who get treated with hydroxychloroquine,
6
SPEAKER_02
appeared not to be getting the disease.
6
SPEAKER_02
Now, you see, in the absence of the time and the resources to do a controlled, well-done, double-blinded study, in the absence of the time to do it, and this is an emergency, this isn t the regular world, you would have thought that people would have embraced this and would have worked together as a global community to put the data pieces together
6
SPEAKER_02
to support use.
6
SPEAKER_02
Now, by the way, by the way, okay, although the drug wasn t approved for the treatment of COVID-19, and by the way, there wasn t any drug approved for COVID-19 because nobody knew what COVID-19 was, but the regulatory communities, they regulate approval of drugs.
6
SPEAKER_02
They don t regulate the prescribing behavior of doctors.
6
SPEAKER_02
They provide recommendations and guidelines and so on, but
6
SPEAKER_02
you know, doctors didn t go to medical school and years and years of training and study pharmacology and study physiology and biochemistry.
6
SPEAKER_02
So they all they have to do is read a recipe and deliver on that recipe.
6
SPEAKER_02
They re there to make medical judgments.
6
SPEAKER_02
So when doctors started making medical judgments to use this, and they were coming away saying, you know what, I believe in, I ve listened to no, no less than a hundred doctors
6
SPEAKER_02
who put this to use and will swear to it that it worked.
6
SPEAKER_02
Now, what I worry about is by being less than inquisitive, supportive, and celebrating that early observation, did we dissuade people from using something that might have saved lives?
6
SPEAKER_02
Did we dissuade people from potentially finding a way to use it prophylactically?
6
SPEAKER_02
Okay.
6
SPEAKER_02
You know, hydroxychloroquine in very low dose prophylactically appears to protect the people in these, in these regions where malaria is prevalent.
6
SPEAKER_02
And by the way, the doctors and healthcare workers on the front line, they really needed someone to find something that gave them an extra margin of protection.
6
SPEAKER_02
So listen, I don t want to speculate as to what the underlying reason for that was, but I do think it was a disservice.
6
SPEAKER_02
And I do think that, you know, listen,
6
SPEAKER_02
I think our government has done a really, really remarkable job in all ways.
6
SPEAKER_02
But the fact that one person s opinion, because the public doesn t agree with the general principles or policies of the individual,
6
SPEAKER_02
they shouldn t be dismissive of something that could have been so impactful in a disease like this.
6
SPEAKER_01
That s how I feel.
6
SPEAKER_01
Let me add something onto that because it s, it s not just the hydroxychloroquine.
6
SPEAKER_01
Uh, there s something going on that I think is important to note.
6
SPEAKER_01
And again, for those of you looking for hope and optimism and all of this, let s take, let s take some hope and optimism from the following fact for the human race.
6
SPEAKER_01
There has never been ever in recorded history,
6
SPEAKER_01
a single enemy that the entire planet has taken aim at.
6
SPEAKER_01
And by my calculations, there s somewhere between 100 million and 200 million physicians, nurses, scientists, engineers, technicians, all laser-like focused on addressing the problem.
6
SPEAKER_01
And what we re seeing right now in week
6
SPEAKER_01
whatever this is of the pandemic in the United States or in the world, if we look at China as day zero, which it may not have been, what we re seeing is only four months of experimental solutions coming to the market.
6
SPEAKER_01
We re seeing the early trickle of antivirals and therapeutics and diagnostics and new ideas.
6
SPEAKER_01
What we re not seeing is that in doctor s offices, in ERs, in science labs,
6
SPEAKER_01
thousands, probably tens of thousands around the world, people not asking for permission, but trying stuff, experimenting, right?
6
SPEAKER_01
That s the way it s done.
6
SPEAKER_01
That s what we humans do best.
6
SPEAKER_01
And I ve got amazing, you know, researchers in CRISPR Cas9, gene editing,
6
SPEAKER_01
technologies and gene therapies in across the board.
6
SPEAKER_01
So what we re seeing is, I talk about the deceptive period of exponential growth and then the disruptive period, we re now seeing the deceptive period of solutions coming over the transom, like that one experiment that came out of France on the hydroxychloroquine and the Z-Pak coming together.
6
SPEAKER_01
My guess is that we will see hundreds, right?
6
SPEAKER_01
I mean, how
6
SPEAKER_01
how much energy Bob and the entire science team at Cellulite have to put into the natural killer cells.
6
SPEAKER_01
There are hundreds and thousands, so hold hope that we are going to not only address this, we re going to crush this.
6
SPEAKER_00
I agree, I couldn t agree with you further.
6
SPEAKER_00
By the way, for those who don t know it, Peter is an MD besides being a rocket scientist and entrepreneur, everything else he is, he s also an MD as well.
6
SPEAKER_00
And so, but the difference in both of these men is that they are so incredibly focused on finding solutions before the problem happens.
6
SPEAKER_00
You know, it s like you see somebody, you know, the old metaphor of a doctor is they work their tails off, they go to school, they go through all this process.
6
SPEAKER_00
And now they see somebody in the lake over here
6
SPEAKER_00
or in the river and they re screaming like they re, you know, they re dying and they jump in, they fight out, they save and pull them out, give them out, come out, save them.
6
SPEAKER_00
And they get out and two more drop are now all of a sudden, they jump out and save the two.
6
SPEAKER_00
By the time they know it, by the time they save two, there s four, then there s eight.
6
SPEAKER_00
They don t have time to go upstream and see who s throwing them in.
6
SPEAKER_00
And these two men are going upstream and seeing who s throwing them in and saying, what do we do to deal with this way upstream instead of a reaction?
6
SPEAKER_00
Because, listen, you play a video game against a child, they win.
6
SPEAKER_00
It s not because they re smarter, quicker or faster.
6
SPEAKER_00
It s because they played this game before.
6
SPEAKER_00
They re able to anticipate.
6
SPEAKER_00
They know the road ahead.
6
SPEAKER_00
And what these two men are doing, incredible researchers and doctors and dear friends of mine, is they re on a cutting edge of what can make this happen.
6
SPEAKER_00
Bob, is there anything we ve not covered that you want people to know about overall about COVID-19 and or just about cellular medicine, what s coming and what they should be aware of so that they can have not only feel more comfortable, but perhaps even more excited about the quality of life they can have long term based on the breakthroughs that are happening now, not 30 years from now.
6
SPEAKER_02
I m convinced that the psychology of this crisis had a tremendous amount to do with the early panicked responses we ve seen, but I m actually getting the sense as I m looking around that people are beginning to realize, you know what?
6
SPEAKER_02
maybe this isn t nearly as horrific as we thought.
6
SPEAKER_02
Maybe now we need to concentrate on recovering and focusing and fueling efforts to come out of this better than before.
6
SPEAKER_02
So, you know, a couple of interesting examples.
6
SPEAKER_02
Short-term pain often yields long-term gain.
6
SPEAKER_02
And some of the gains we re going to have, I believe, will be in the understanding that infectious diseases, we shouldn t be treating them with antibiotics and antivirals that are custom designed for one pathogen or another.
6
SPEAKER_02
We need to come up with a solution that across the board protects against infectious disease.
6
SPEAKER_02
You already said it, Tony, and so did you, Peter.
6
SPEAKER_02
It s all about the immune system, okay?
6
SPEAKER_02
There are people you know who never get sick, right?
6
SPEAKER_02
They never get sick because they just happen to have, because of genetics or lifestyle or whatnot, they have an immune system that is on constant alert.
6
SPEAKER_02
They have the best military, you know, on the planet when it comes to defending against pathogens and so on.
6
SPEAKER_02
Let s take advantage of this opportunity to better understand how cellular immunotherapy, something that s already revolutionized in the treatment of cancer, may change
6
SPEAKER_02
the shape and reshape how we treat infectious diseases in the future.
6
SPEAKER_02
And if that happens, we solve Peter s problem, which is preparedness for the next pandemic.
6
SPEAKER_02
And we also, we also will transform
6
SPEAKER_02
the tools doctors have that will keep people from ever having these massive super infections, resistant microorganisms.
6
SPEAKER_02
We ve all heard of MRSA and things like that.
6
SPEAKER_02
So if we come, I think we can come out of this better than when we entered into it.
6
SPEAKER_02
And look, I ve devoted 25 years of my life to cellular medicine.
6
SPEAKER_02
I can tell you that these tools astound me every day.
7
SPEAKER_00
They re nature s repair kit, nature s toolkit, and we re going to deploy them.
7
SPEAKER_00
We re very grateful that the FDA has been working so hard to help groups like ours do the work and prove that these products are safe and effective.
7
SPEAKER_00
And I m optimistic about where we re going to come out of this.
7
SPEAKER_01
And Bob, let me just add, because it s important to note under your leadership,
7
SPEAKER_01
Cellularity has built what is the world-class manufacturing, the better part of $100 million, to be able to actually
7
SPEAKER_01
take the placenta and take out the natural killer cells, the stem cells, create medicines and therapeutics out of that at scale, where you have the ability to produce what will be millions of doses that could be frozen on standby, both in the military or hospitals, wherever they re needed.
7
SPEAKER_01
And these actually, when they re frozen, can last decades.
7
SPEAKER_01
So there s a potential to be ready in the future
7
SPEAKER_01
And I think it s worth also mentioning, since the three of us are focused on this, that we ve been working on a program called Fountain and Fountain Life that will be a way that the
7
SPEAKER_01
average consumer can get access to these stem cells.
7
SPEAKER_01
I know we have a number of Fountain Life friends and family who are going to be watching this and viewing this.
7
SPEAKER_01
And it s how do we deliver those stem cells that are the, you know, the original boot disc for the human body to be able to rejuvenate and revitalize our physiology.
7
SPEAKER_01
I just want to mention that work a little bit.
7
SPEAKER_00
Yeah, I mean, we know that stem cells and cellular products can be used to restore the regenerative engine in an individual and allow them to respond to illness, disease, injury the way they did when they were young and youthful.
7
SPEAKER_00
And I m very excited, you know, Tony alluded to up front what cellular medicine can do for orthopedic, joint, and soft tissue injuries.
7
SPEAKER_00
You know, the world kind of knows that this is here and coming.
7
SPEAKER_00
We re still working through the process of getting these approaches
7
SPEAKER_00
through the rigorous programs necessary to prove safety and efficacy and so on.
7
SPEAKER_00
But I m, again, extremely optimistic that what we re going through today and what s happening around the world in treating patients with degenerative diseases and so on will change the tool set doctors have in the next generation, in the generation we ve just entered into, so that people actually live healthier, longer, and higher performance lives going forward.
7
SPEAKER_02
I do want to bring one thing up, because when you bring up the term stem cells, it s kind of the Wild West in the United States.
7
SPEAKER_02
I remember, Bob, before I met you, there s all these different types of stem cells.
7
SPEAKER_02
They wanted to take my own fatty tissue and convert it.
7
SPEAKER_02
And then you gave me a quick education.
7
SPEAKER_02
So before we go, since, you know, cellular therapy is so important, and there are some people that knowing the pandemic, or there s a solution for something as big as somebody in the hospital who s on a ventilator is available with NK cells.
7
SPEAKER_02
and that it s going there, it d be nice for them to understand what s available now so they don t also get pulled into something that isn t effective.
7
SPEAKER_02
You and I both know for elbows, shoulders, things like my entire rotator cuffs, I mean to have not three, six months and some people after three or six months, they still can t lift their shoulder above their arm.
7
SPEAKER_02
for me to have perfect use, with the kind of demand you know I make, you know this, you ve seen the studies on my body, jumping a thousand times in a day, you know, in an audience of, you know, 12 hours, you know, burning, you know, 11,500 calories in a period of time of 12 hours.
7
SPEAKER_02
You ve seen those studies and you ve seen the impact the stem cells have had, but can you take just one second before we go and give people an understanding of the different types of choices so they don t get pulled into fake science, because that s part of the problem.
7
SPEAKER_02
Some people hear stem cell,
7
SPEAKER_02
They think it s the same as doing PRP or something else.
7
SPEAKER_02
I understand the potency is different depending upon the source.
7
SPEAKER_02
Can you touch on that just for a second?
7
SPEAKER_02
we wrap up.
7
SPEAKER_00
So, you know, Tony, I m very vested in the technology around stem cells that are recovered from the postpartum placenta because these cells are young, they ve gone through nature s quality control process, and they basically have the biological attributes necessary to restore the functionality.
7
SPEAKER_00
They have anti-inflammatory properties and pro-regenerative properties.
7
SPEAKER_00
We re working diligently to demonstrate that in a whole series of clinical indications.
7
SPEAKER_00
newborn derived cells have a lot of advantages over cells derived from an adult, such as from adipose tissue or from bone marrow or whatnot.
7
SPEAKER_00
Um, and as I mentioned before, they re highly scalable.
7
SPEAKER_00
They can be produced so that they re off the shelf on demand, long shelf life products, one size fits all.
7
SPEAKER_00
And so that s, those are the kinds of cells I think people need to be looking for because they re, they re reliable.
7
SPEAKER_00
Um, and we believe that,
7
SPEAKER_00
Ultimately, people are going to want to go back and be treated more than once, and they re going to want to have the consistency of a pharmaceutical-like product.
7
SPEAKER_00
So I think that s the platform of technology that has the greatest merit.
7
SPEAKER_00
But there are going to be people who want to go places where they can have their own adipose tissue removed and cells derived from that.
7
SPEAKER_00
There s a lot of reports, and there s even some data supporting that that s useful.
7
SPEAKER_00
But at the end of the day,
7
SPEAKER_00
Regenerative medicine using either cells or cell byproducts is coming into prime time.
7
SPEAKER_00
People are going to have lots of choices in front of them.
7
SPEAKER_00
You need to find places which are using cells produced under rigorous controls and quality standards, and you have to work with reputable groups that are either in an investigational stage of development or they re working in a jurisdiction where it s permitted.
7
SPEAKER_02
Because the problem is our stem cells in the average person drop off a cliff after about 30 as a percentage.
7
SPEAKER_02
So if you re taking them from yourselves, you re not getting the same potency, obviously, than if you re taking brand new cells that are coming from the placenta as well.
7
SPEAKER_02
It s an important part to notice in terms of impact.
7
SPEAKER_01
Maya, before we leave you, Peter, any final thoughts?
7
SPEAKER_01
I just want to bring it back to the key messages we have here.
7
SPEAKER_01
For me, I think one of the things that people need more than ever is hope and optimism.
7
SPEAKER_01
Open optimism because it s been hard for so many individuals who ve lost their jobs lost their savings back up in their companies and so forth open optimism comes on a couple points number one what we re seeing and believe and trending towards is that the.
7
SPEAKER_01
mortality rate is nowhere near as bad as predicted.
7
SPEAKER_01
Number two, we re going to see a tsunami of different solutions that are coming, antivirals, therapeutics, vaccines that are coming.
7
SPEAKER_01
I run a global
7
SPEAKER_01
prediction engine, and right now the prediction is that we ll see a vaccine before the end of the year, maybe mid-December.
7
SPEAKER_01
That would be great, going into the next flu season, at least on the northern hemisphere.
7
SPEAKER_01
The other thing that s important is that
7
SPEAKER_01
You know, if you look at every economic crisis over time, there is a massive rebound.
7
SPEAKER_01
And we ll see, you know, a lot of the companies that were just hanging on, employing people just barely, but not thriving.
7
SPEAKER_01
They re going to, as we see in every Darwinian evolution, they re going to die and go away.
7
SPEAKER_01
But like we saw out of 2008, we saw WhatsApp and Venmo and Uber and Airbnb and the invention of massive amounts.
7
SPEAKER_01
So if you re at home and you re in this global quiet period,
7
SPEAKER_01
besides spending time meditating, eating right, sleeping well, exercising, which are things that you can do for immune system right now, gotta mention those.
7
SPEAKER_01
This is the time to be inventive, to be inventive about, you know, if you re an entrepreneur, how do I create digital businesses?
7
SPEAKER_01
How do I find problems out there?
7
SPEAKER_01
Because this last three months,
7
SPEAKER_01
is going to accelerate the future.
7
SPEAKER_01
What we ve been doing here digitally is going to bring us faster and faster in this decade ahead.
7
SPEAKER_01
So there are reasons for hope.
7
SPEAKER_01
There are reasons for optimism.
7
SPEAKER_01
And I see those all the time.
7
SPEAKER_01
So I want to share that, Tony, with everyone here today and with you, Bob.
7
SPEAKER_01
I love you, brother.
7
SPEAKER_01
You re brilliant.
7
SPEAKER_02
Thank you both.
7
SPEAKER_02
We re going through a bit of a winter, but winter is followed by spring and you can feel the beginnings of spring starting to crack as you start to see the numbers flatten and come down, a little less fear in people, people reevaluating, seeing real numbers and all these mass drive of solutions that are moving us forward.
7
SPEAKER_02
So let s bring forward together the opportunities are greater than they ve ever been in human history.
7
SPEAKER_02
We keep our intelligence.
7
SPEAKER_02
We are a resilient species, no little floating through the air or something, and somebody sneezed on us, stop this, in a million years, and it s not going to happen now.
7
SPEAKER_02
So let the fear aside, focus on the solutions.
7
SPEAKER_02
Thank you, Bob, for bringing forth some of the most important solutions, not just for COVID-19, but for we as a human race moving forward to have healthier, stronger, and more high-performance lives, ones we can really enjoy.
7
SPEAKER_02
It s not just length of life, but quality of life that self-therapy can make
8
SPEAKER_01
big difference for Peter.
8
SPEAKER_01
Thank you for being my dear friend and partner.
8
SPEAKER_01
God bless you all and we ll see you soon.
8
SPEAKER_01
Live strong, live with passion, and God bless.
8
SPEAKER_02
Take care, everybody.
8
SPEAKER_02
See you soon.
8
SPEAKER_00
The Tony Robbins Podcast is directed by Tony Robbins and produced by the Tony Robbins team.
8
SPEAKER_00
Special thanks to Dr. Bob Hariri and Dr. Peter Diamandis.